Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Simmons

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|January 29, 2013
Aptamer-based nanoparticles for cancer targetingLucas Torres Miranda Sá, Suzanne Simmons, Sotiris Missailidis, et al.
Stroke|September 24, 2011
Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhageSherry H-Y Chou, Po-Shun Lee, Rachael G Konigsberg, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|January 29, 2013
Aptamer-based nanoparticles for cancer targetingLucas Torres Miranda Sá, Suzanne Simmons, Sotiris Missailidis, et al.
Stroke|September 24, 2011
Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhageSherry H-Y Chou, Po-Shun Lee, Rachael G Konigsberg, et al.
Pageof 1